返回 Agenda
Session Chair(s)
Michael Brandkamp
Managing Director
High-Tech Gruenderfonds, Germany
Speaker(s)
Presentation
Melanie Carr
European Medicines Agency, Netherlands
Head of Stakeholders and Communication Division
Andreas Schmidt, DRSC
AYOXXA Biosystems, Germany
CEO
New Treatment Paradigms – Regulatory Challenges for SMEs
Ulrich Dauer, DRSC
OMEICOS, Germany
CEO
Presentation
Sam Wadsworth, PHD
Dimension Therapeutics, United States
Chief Scientific Officer
The Role of Venture Funds in Enabling Innovation
Frank Kalkbrenner
Boehringer Ingelheim Venture Fund, Germany
Corporate Vice President
The Role of Industry in the Innovation Ecosystem
Joseph Scheeren, PHARMD
Scheeren HealthCare LLC, United States
Founder